Morgens Waterfall Vintiadis & Co Inc / ESPR
Morgens Waterfall Vintiadis & Co Inc’s Esperion Therapeutics Inc Ne Position
Does Morgens Waterfall Vintiadis & Co Inc own Esperion Therapeutics Inc Ne (ESPR)? Not currently — the last reported position was 35.0K shares worth $2M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q2 2020
Shares
35.0K
% of Portfolio
+1.15%
Quarters Held
2
position exited
Position History ESPR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Morgens Waterfall Vintiadis & Co Inc’s full portfolio or all institutional holders of ESPR.